EVA is a medical device company offering a technology designed to prevent migration of AAA grafts. The firm was also addressing expanding its technology into use with a specially designed revolutionary surgical device that treats AAAs in a minimally invasive manner that is safer, more effective, more durable, and less costly than other commercially available treatment options.
